151 related articles for article (PubMed ID: 33870468)
1. Treatment with senicapoc in a porcine model of acute respiratory distress syndrome.
Petersen AG; Lind PC; Jensen AB; Eggertsen MA; Granfeldt A; Simonsen U
Intensive Care Med Exp; 2021 Apr; 9(1):20. PubMed ID: 33870468
[TBL] [Abstract][Full Text] [Related]
2. Treatment with senicapoc, a K
Petersen AG; Lind PC; Mogensen S; Jensen AB; Granfeldt A; Simonsen U
Br J Pharmacol; 2022 May; 179(10):2175-2192. PubMed ID: 34623632
[TBL] [Abstract][Full Text] [Related]
3. Effect of the KCa3.1 blocker, senicapoc, on cerebral edema and cardiovascular function after cardiac arrest - A randomized experimental rat study.
Hansen FB; Secher N; Mattson T; Løfgren B; Simonsen U; Granfeldt A
Resusc Plus; 2021 Jun; 6():100111. PubMed ID: 34223371
[TBL] [Abstract][Full Text] [Related]
4. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.
Gadek JE; DeMichele SJ; Karlstad MD; Pacht ER; Donahoe M; Albertson TE; Van Hoozen C; Wennberg AK; Nelson JL; Noursalehi M
Crit Care Med; 1999 Aug; 27(8):1409-20. PubMed ID: 10470743
[TBL] [Abstract][Full Text] [Related]
5. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model.
Steinberg J; Halter J; Schiller H; Gatto L; Carney D; Lee HM; Golub L; Nieman G
Shock; 2005 Oct; 24(4):348-56. PubMed ID: 16205320
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the potassium channel K
Staal RGW; Khayrullina T; Zhang H; Davis S; Fallon SM; Cajina M; Nattini ME; Hu A; Zhou H; Poda SB; Zorn S; Chandrasena G; Dale E; Cambpell B; Biilmann Rønn LC; Munro G; Mӧller T
Eur J Pharmacol; 2017 Jan; 795():1-7. PubMed ID: 27876619
[TBL] [Abstract][Full Text] [Related]
7. [Effects of mechanical ventilation with different tidal volumes on right ventricular hemodynamics in acute respiratory distress syndrome rats].
Liu J; Zhang H; Shi Y; Wang T; Zuo X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):49-52. PubMed ID: 33565400
[TBL] [Abstract][Full Text] [Related]
8. Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis.
Guo L; Wang W; Zhao N; Guo L; Chi C; Hou W; Wu A; Tong H; Wang Y; Wang C; Li E
Crit Care; 2016 Jul; 20(1):226. PubMed ID: 27448995
[TBL] [Abstract][Full Text] [Related]
9. Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial.
Granfeldt A; Andersen LW; Vallentin MF; Hilberg O; Hasselstrøm JB; Sørensen LK; Mogensen S; Christensen S; Grejs AM; Rasmussen BS; Kristiansen KT; Strøm T; Johansen IS; Schjørring OL; Simonsen U
Acta Anaesthesiol Scand; 2022 Aug; 66(7):838-846. PubMed ID: 35403225
[TBL] [Abstract][Full Text] [Related]
10. A rat model of acute respiratory distress syndrome (ARDS): Part 1. Time dependency of histological and pathological changes.
Germann PG; Häfner D
J Pharmacol Toxicol Methods; 1998 Aug; 40(2):101-7. PubMed ID: 10100499
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia-reperfusion injury.
Nassoiy SP; Babu FS; LaPorte HM; Majetschak M
Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):16-26. PubMed ID: 28815665
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome.
Schwartz MD; Moore EE; Moore FA; Shenkar R; Moine P; Haenel JB; Abraham E
Crit Care Med; 1996 Aug; 24(8):1285-92. PubMed ID: 8706481
[TBL] [Abstract][Full Text] [Related]
13. Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.
Paka L; Smith DE; Jung D; McCormack S; Zhou P; Duan B; Li JS; Shi J; Hao YJ; Jiang K; Yamin M; Goldberg ID; Narayan P
World J Gastroenterol; 2017 Jun; 23(23):4181-4190. PubMed ID: 28694658
[TBL] [Abstract][Full Text] [Related]
14. Parecoxib reduced ventilation induced lung injury in acute respiratory distress syndrome.
Meng FY; Gao W; Ju YN
BMC Pharmacol Toxicol; 2017 Mar; 18(1):25. PubMed ID: 28356130
[TBL] [Abstract][Full Text] [Related]
15. Comparison of prone positioning and high-frequency oscillatory ventilation in patients with acute respiratory distress syndrome.
Papazian L; Gainnier M; Marin V; Donati S; Arnal JM; Demory D; Roch A; Forel JM; Bongrand P; Brégeon F; Sainty JM
Crit Care Med; 2005 Oct; 33(10):2162-71. PubMed ID: 16215365
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the K
Organ L; Bacci B; Koumoundouros E; Kimpton WG; Samuel CS; Nowell CJ; Bradding P; Roach KM; Westall G; Jaffar J; Snibson KJ
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):539-550. PubMed ID: 28060543
[TBL] [Abstract][Full Text] [Related]
17. Lidocaine attenuates hyperoxic lung injury in rabbits.
Takao Y; Mikawa K; Nishina K; Maekawa N; Obara H
Acta Anaesthesiol Scand; 1996 Mar; 40(3):318-25. PubMed ID: 8721462
[TBL] [Abstract][Full Text] [Related]
18. Inhaled nitric oxide does not prevent endotoxin-induced lung injury in rabbits.
Nishina K; Mikawa K; Takao Y; Obara H
Acta Anaesthesiol Scand; 1997 Mar; 41(3):399-407. PubMed ID: 9113187
[TBL] [Abstract][Full Text] [Related]
19. Natural inhibitors of neutrophil function in acute respiratory distress syndrome.
Geerts L; Jorens PG; Willems J; De Ley M; Slegers H
Crit Care Med; 2001 Oct; 29(10):1920-4. PubMed ID: 11588452
[TBL] [Abstract][Full Text] [Related]
20. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
Li J; Luo Z; Li X; Huang Z; Han J; Li Z; Zhou Z; Chen H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):39-44. PubMed ID: 28459402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
